cliexa
PrivateLast Round
Seed Round
Feb 26, 2026
Total Funding Raised
$4.05M
Momentum Score
50 /100
Company Overview
cliexa is a healthcare technology company that provides an AI-powered digital health platform for real-time data integration, patient engagement, and clinical decision support.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Revenue Cycle, Patient Engagement, Vertical SaaS, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
cliexa Comps
Public and private peers based on sector, stage, and business model.
cliexa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Feb 26, 2026 | ||||
| Seed | Feb 11, 2025 | ||||
| Grant | May 21, 2020 | ||||
| Grant | Oct 7, 2019 |
cliexa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| American College of Cardiology Foundation | Seed |
| StartUp Health | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors grew 140% MoM, reaching 4.2K.
- Mar 27, 2026
Partnered with American College of Cardiology on AI solutions.
cliexa Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about cliexa's valuation, stock price, and market status.
